Watimar, Rachel .

HRN: 12-50-49  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2024
CEFUROXIME 1.5GM (VIAL)
05/20/2024
05/21/2024
IV
1.5gm
Q8 X 3 Doses
S/P NSVD (RHU Delivery) With 2nd Deg And Repair; Inc WBC 29.2
Waiting Final Action 
05/21/2024
CEFUROXIME 500MG (TAB)
05/21/2024
05/28/2024
PO
1 Tab
BID
SP NSVD; Postpartum Hemorrhage
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: